H1 sales up 5% at same forex (Il Sole 24 Ore Radiocor) - Zurich, 25 Jul - The Swiss pharmaceutical group Roche said that in the first half diluted core earnings per share rose 1% to 10.23 francs. At constant exchange rates, core EPS increased 9%.

Sales were flat at 29.848 billion francs, but rose 5% at constant exchange rates.

Core operating profit was 11.293 billion francs, up a reported 4% and 11% at constant exchange rates.

The company increased its outlook for 2024 earnings. Core earnings per share are targeted to grow within a high single digit range at constant exchange rates, excluding the impact from the resolution of tax disputes in 2023.

Roche expects an increase in sales in the mid single digit range at constant exchange rates.

The company expects to further increase its dividend in Swiss francs.

AAA-Web

(RADIOCOR) 25-07-24 08:52:07 (0203) 5 NNNN